Intranasal Octreotide (DP1038)

octreotide · Dauntless Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Intranasal Octreotide (DP1038), covering 2017-05-12 to 2017-05-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers [Phase 1]